Literature DB >> 8691154

Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C.

K S Campbell1, M Dessing, M Lopez-Botet, M Cella, M Colonna.   

Abstract

Natural killer (NK) cells express killer inhibitory receptors that mediate negative regulation of NK cell cytotoxicity upon binding to MHC class I molecules on target cells. Unrelated inhibitory receptors on B cells have recently been shown to function through recruitment of phosphotyrosine phosphatase 1C (PTP-1C). Here, we show that a human killer inhibitory receptor specific for HLA-C also recruits PTP-1C after phosphorylation induced either by the pharmacological agent phenylarsine oxide or by conjugation with target cells. This recruitment is mediated by the binding of specific cytoplasmic phosphotyrosine-containing sequences to PTP-1C. These results implicate PTP-1C as a cytosolic component of the negative signaling pathway through NK cell inhibitory receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8691154      PMCID: PMC2192677          DOI: 10.1084/jem.184.1.93

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  Inhibition of selective signaling events in natural killer cells recognizing major histocompatibility complex class I.

Authors:  D S Kaufman; R A Schoon; M J Robertson; P J Leibson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

2.  Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.

Authors:  N Wagtmann; R Biassoni; C Cantoni; S Verdiani; M S Malnati; M Vitale; C Bottino; L Moretta; A Moretta; E O Long
Journal:  Immunity       Date:  1995-05       Impact factor: 31.745

3.  Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.

Authors:  M Colonna; J Samaridis
Journal:  Science       Date:  1995-04-21       Impact factor: 47.728

Review 4.  Natural killer cells. Right-side-up and up-side-down NK-cell receptors.

Authors:  W M Yokoyama
Journal:  Curr Biol       Date:  1995-09-01       Impact factor: 10.834

5.  Induction of hyperphosphorylation and activation of the p56lck protein tyrosine kinase by phenylarsine oxide, a phosphotyrosine phosphatase inhibitor.

Authors:  C Oetken; M von Willebrand; A Marie-Cardine; T Pessa-Morikawa; A Ståhls; S Fisher; T Mustelin
Journal:  Mol Immunol       Date:  1994-12       Impact factor: 4.407

6.  A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP.

Authors:  G M Doody; L B Justement; C C Delibrias; R J Matthews; J Lin; M L Thomas; D T Fearon
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

7.  Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes.

Authors:  A D'Andrea; C Chang; K Franz-Bacon; T McClanahan; J H Phillips; L L Lanier
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

Review 8.  Of ITAMs and ITIMs: turning on and off the B cell antigen receptor.

Authors:  M L Thomas
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

9.  Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton.

Authors:  S Valitutti; M Dessing; K Aktories; H Gallati; A Lanzavecchia
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

10.  Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.

Authors:  A Moretta; S Sivori; M Vitale; D Pende; L Morelli; R Augugliaro; C Bottino; L Moretta
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

View more
  42 in total

1.  H-2Dd engagement of Ly49A leads directly to Ly49A phosphorylation and recruitment of SHP1.

Authors:  M R Daws; M Eriksson; L Oberg; A Ullén; C L Sentman
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

2.  Alloreactivity and association of human natural killer cells with the major histocompatibility complex.

Authors:  E Mavoungou; A Sall; V Poaty-Mavoungou; F S Toure; P Yaba; A Delicat; J Lansoud-Soukate
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

3.  Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor.

Authors:  A Cambiaggi; C Verthuy; P Naquet; F Romagné; P Ferrier; R Biassoni; A Moretta; L Moretta; E Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

4.  Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81.

Authors:  T Miyazaki; U Müller; K S Campbell
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

Review 5.  Natural killer cells: integrating diversity with function.

Authors:  Kuldeep Cheent; Salim I Khakoo
Journal:  Immunology       Date:  2009-04       Impact factor: 7.397

6.  Natural killer activating receptors trigger interferon gamma secretion from T cells and natural killer cells.

Authors:  O Mandelboim; S Kent; D M Davis; S B Wilson; T Okazaki; R Jackson; D Hafler; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

7.  Alternatively spliced forms of human killer inhibitory receptors.

Authors:  C Döhring; J Samaridis; M Colonna
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

Review 8.  HLA-C revisited. Ten years of change.

Authors:  C S Falk; D J Schendel
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

9.  Self and viral peptides can initiate lysis by autologous natural killer cells.

Authors:  O Mandelboim; S B Wilson; M Valés-Gómez; H T Reyburn; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

Review 10.  Recognition of tumors by the innate immune system and natural killer cells.

Authors:  Assaf Marcus; Benjamin G Gowen; Thornton W Thompson; Alexandre Iannello; Michele Ardolino; Weiwen Deng; Lin Wang; Nataliya Shifrin; David H Raulet
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.